The Effectiveness of Intermittent Fasting and Behavioral Economics Intervention on Weight Control in Obese Patients
Launched by MAHIDOL UNIVERSITY · Feb 7, 2024
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The investigators will collect the participant characteristics (age, gender, smoking history, comorbid diseases including history of previous stroke, myocardial infarction, angina, hypertension, dyslipidemia, T2DM, risk of osteoporosis, and all medication lists) at the first visit.
* Physiological parameters:
1. Body composition will be assessed by the Bioelectrical Impedance at the first visit and at each follow-up visit (1 month, 2 months, 4 months, 6 months, 9 months, and 12 months).
2. Peripheral venous blood sample (15mL: clotted blood 9mL and EDTA blood 6 mL) and urinalysis will...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18-65 year
- • BMI start at 25.0 kg/m2 (above 24.99 kg/m2)
- • Weight change less than 5% in 6-month
- • Ability and willingness to provide informed consent
- Exclusion Criteria:
- • Pregnant women or breed feeding
- • Kidney disease/ Liver disease
- • Abnormal Thyroid hormone, abnormal GI function
- • Postoperative bariatric surgery
- • Drug control weight or reduce appetite
- • Drug abuse
- • Mental illness
About Mahidol University
Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ratchathewi, Bangkok, Thailand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported